Jing Hu

18PUBLICATIONS
16CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Chemical engineering designGlycoconjugatesInnate immunityMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Apr 13, 2026
Photocaging the C6-carboxylate of β-glucuronide prodrugs enables spatiotemporally controlled release of anticancer agents <i>via</i> a dual activation strategy.

Junjie Fu, Dianya Yong, Jie Liu

|Apr 01, 2026
Industrial Chemical Glycan Synthesis (ICGS): Process Intensification of Glycosylations.

Chunjun Qin, Junjie Fu, Guangzong Tian

|Mar 24, 2026
Design and Optimization of Lysosome-Targeted β-Galactoside Senolytic Prodrugs: Harnessing the Aromatic Ring of Self-Immolative Linkers.

Jie Liu, Xiaoke Liu, Haitian Fu

|Feb 25, 2026
Preclinical development of a well-defined semisynthetic glycoconjugate vaccine against <i>Haemophilus influenzae</i> type b.

Wei Han, Chunjun Qin, Wei Tong

|Apr 25, 2025
Chemical synthesis elucidates the absolute configuration and key antigenic epitope of <i>Vibrio cholerae</i> serotype O100 O-antigen.

Guodong Chen, Guangzong Tian, Jing Hu

|Mar 26, 2025
Tandem activated caged galactoside prodrugs: advancing beyond single galactosidase dependence.

Yunying Tan, Jie Liu, Dianya Yong

Pageof 3

Frequent Collaborators

15 joint publications

Jian Yin

6 joint publications

Chunjun Qin

5 joint publications

Junjie Fu

5 joint publications

Peter H Seeberger